StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Downgrades ZS Pharma (ZSPH) to Neutral
November 9, 2015 7:17 AM
JPMorgan downgraded ZS Pharma (NASDAQ: ZSPH) from Overweight to Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades
Next Articles
Morgan Stanley Downgrades ZS Pharma (ZSPH) to Equalweight
November 9, 2015 7:16 AM
ZS Pharma (ZSPH) Reports Interim Results From Long-Term Safety Study of ZS-9
November 9, 2015 7:14 AM
Credit Suisse Downgrades ZS Pharma (ZSPH) to Neutral on Takeover
November 9, 2015 6:24 AM
AstraZeneca (AZN) to Acquire ZS Pharma (ZSPH) in $2.7B Deal
November 6, 2015 6:36 AM
Form 8-K ZS Pharma, Inc. For: Nov 05
November 6, 2015 6:07 AM
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion
November 6, 2015 2:19 AM
